Filing Details

Accession Number:
0001209191-20-027959
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-08 16:53:04
Reporting Period:
2020-05-06
Accepted Time:
2020-05-08 16:53:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1760682 Dashyant Dhanak 1801 Augustine Cut-Off
Wilmington DE 19803
Evp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-06 961 $65.42 20,948 No 4 M Direct
Common Stock Disposition 2020-05-06 961 $96.84 19,987 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-05-06 961 $0.00 961 $65.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,486 2028-12-10 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  2. This includes an aggregate of 18,801 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
  3. Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25.00% vesting on December 10, 2019 and the remainder vesting monthly over three years.